A peer-reviewed study on voice AI and depression screening shows why demographic portability testing matters before deploying clinical AI tools.
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Strategies To Minimize Participant And Healthcare Provider Burden
Patient-reported outcomes (PROs) are vital for clinical trials but can burden participants and providers. Discover strategies and practical solutions to ease these burdens and improve data quality.
-
Designing Technology for Real-World Research
From workflow design to smarter notifications, practical site-focused solutions can reduce complexity, improve efficiency, and better support clinical research teams.
-
How A Remote ePRO Solution Helped Reduce Patient Burden
Discover how transitioning multiple studies from on-site to at-home assessments improved patient retention and recruitment for a global neurology program.
-
What Patients Are Asking For In Clinical Trials
Global insights show how travel demands, uneven compensation, and overlooked caregiver burden undermine trial participation — making flexible, patient-centered approaches essential.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
Expanding Flexibility Of eCOA Data Collection With Controlled Interview Mode
Discover how the interview mode constitutes an additional data entry mode for ePROs when clinical trial participants cannot go to the study site for a scheduled visit.
-
Don't Just Swap The Engine. Redesign The Factory.
Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.
-
Real-World Evidence - Where Are We Now?
Notwithstanding ongoing confusion over the concepts of “real-world data” and “real-world evidence” in 2022, more than 5 years after the passage of the 21st Century Cures Act, the FDA continues to evaluate such data and evidence as it considers regulatory decisions.
-
Elosity's Agile RTSM Build Experience
Modern RTSM requires agility. Learn how real-time visibility, flexible configuration, and faster amendments help teams execute studies with greater efficiency.
-
The Impact Of Clinical Trial Payments On Site-Sponsor Relationships
The sponsor-site relationship relies on good faith, but late payments sow mistrust. Experts from BMS and CenExel Clinical Research explain how consolidating payment systems benefits both parties.
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
RECENT NEWSLETTERS
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos